School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

NEOGENOMICS INC NEO

Healthcare · Diagnostics & Research

$16.35last close 2026-10-09 · market cap $2.13B · delayed data

Trailing returns

1M-7.42%
3M+11.00%
6M+105.92%
1Y+82.27%
5Y-60.85%

Basis: Adjusted daily closes.

What it does

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.

Open NEO in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies